Printer Friendly
The Free Library
14,380,416 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

First Clinical Care Options for Hepatitis.


First Clinical Care Options for Hepatitis, June 19-22

For 13 years the Clinical Care Options for HJV HJV Hjemmeværnet (Danish National Guard)
HJV Hemojuvelin
HJV Hypocritae Jacobeae Virus
HJV Highland J-Virus
 Symposium has brought together about 300 frontline HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  doctors for an annual meeting on treating HIV. This year the sponsor, iMedOptions, is beginning a similar meeting on viral hepatitis viral hepatitis
n.
Any of various forms of hepatitis caused by a virus.


viral hepatitis,
n an inflammatory condition of the liver, caused by the hepatitis viruses: A, B, C, delta, E, F, G, or H.
. The First Annual Clinical Care Options for Hepatitis Symposium, for "experienced, front-line, primary care physicians, gastroenterologists and infectious disease specialists involved in the care of patients with viral hepatitis" will be held June 19-22, 2003, in Laguna Niguel, California Laguna Niguel is a city located in southern Orange County, California. The name "Laguna Niguel" is derived from the Spanish word "Laguna" which means lagoon and the word "Nigueli" which was the name of a Juaneno Indian village once located on Aliso Creek. .

For more information visit http://imedoptions.com/hep2003 or phone 800-878-6260.
COPYRIGHT 2003 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:conference on hepatitis treatment
Publication:AIDS Treatment News
Article Type:Calendar
Geographic Code:1USA
Date:May 30, 2003
Words:96
Previous Article:Atazanavir background documents available.(new protease inhibitor developed)(Brief Article)
Next Article:Surprising causes of death in Texas hospital study: safety net questions.
Topics:



Related Articles
Retroviruses Conference: Johns Hopkins Report.(Hopkins HIV Report)
GILEAD SUBMITS MAA TO EMEA FOR ADEFOVIR DIPIVOXIL 10 MG.
EUROPEAN CPMP GIVES POSITIVE RECOMMENDATION FOR HEPSERA.
VERTEX/MITSUBISHI TO DEVELOP HCV ORAL PROTEASE INHIBITOR.
Hepatitis coinfection: two major studies published.
Dear reader.(Letter from the Editor)(liver failure is leading cause of death among people with HIV in the US)
Current challenges in hepatitis C.(Policy Matters)
PHARMASSET TO DEVELOP CLEVUDINE FOR HEPATITIS B.
MIGENIX INITIATES ENROLLMENT IN PHASE IIB HEPATITIS TRIAL.
TELBIVUDINE APPROVED IN SWITZERLAND FOR CHRONIC HEPATITIS B.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles